<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Solypertine</id>
	<title>Solypertine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.org/index.php?action=history&amp;feed=atom&amp;title=Solypertine"/>
	<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Solypertine&amp;action=history"/>
	<updated>2026-04-27T03:32:08Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.org/index.php?title=Solypertine&amp;diff=6428271&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.org/index.php?title=Solypertine&amp;diff=6428271&amp;oldid=prev"/>
		<updated>2025-03-05T06:27:33Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Solypertine ==&lt;br /&gt;
&lt;br /&gt;
[[File:Solypertine.svg|Chemical structure of Solypertine|thumb|right]]&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Solypertine&amp;#039;&amp;#039;&amp;#039; is a chemical compound that was investigated for its potential use as an [[antipsychotic]] medication. It belongs to the class of [[phenothiazine]] derivatives, which are known for their antipsychotic and [[antihistamine]] properties. Solypertine was developed in the mid-20th century but did not achieve widespread clinical use.&lt;br /&gt;
&lt;br /&gt;
== Chemical Properties ==&lt;br /&gt;
Solypertine is a member of the phenothiazine class, characterized by a three-ring structure with a sulfur and nitrogen atom. The chemical structure of Solypertine is similar to other phenothiazines, which are known for their ability to block [[dopamine receptors]] in the brain, a mechanism thought to be responsible for their antipsychotic effects.&lt;br /&gt;
&lt;br /&gt;
== Pharmacology ==&lt;br /&gt;
Solypertine acts primarily as a [[dopamine antagonist]], which means it blocks the action of dopamine, a neurotransmitter involved in mood, behavior, and cognition. By inhibiting dopamine receptors, Solypertine was hypothesized to reduce symptoms of [[schizophrenia]] and other psychotic disorders. However, its exact mechanism of action and efficacy in clinical settings were not fully established.&lt;br /&gt;
&lt;br /&gt;
== Clinical Use ==&lt;br /&gt;
Although Solypertine was initially developed as an antipsychotic, it did not become a standard treatment. The development of more effective and safer antipsychotic medications, such as [[chlorpromazine]] and [[haloperidol]], overshadowed Solypertine. As a result, it remains a compound of historical interest rather than a therapeutic agent in modern medicine.&lt;br /&gt;
&lt;br /&gt;
== Side Effects ==&lt;br /&gt;
Like other phenothiazines, Solypertine was associated with a range of side effects. These could include [[sedation]], [[extrapyramidal symptoms]] (such as tremors and rigidity), and [[anticholinergic effects]] (such as dry mouth and blurred vision). The potential for these side effects, along with the availability of better alternatives, limited its use in clinical practice.&lt;br /&gt;
&lt;br /&gt;
== Research and Development ==&lt;br /&gt;
Research into Solypertine contributed to the understanding of phenothiazine derivatives and their role in treating psychiatric disorders. Although it did not become a widely used medication, studies on Solypertine helped pave the way for the development of newer antipsychotic drugs with improved safety and efficacy profiles.&lt;br /&gt;
&lt;br /&gt;
== Related Pages ==&lt;br /&gt;
* [[Antipsychotic]]&lt;br /&gt;
* [[Phenothiazine]]&lt;br /&gt;
* [[Dopamine antagonist]]&lt;br /&gt;
* [[Schizophrenia]]&lt;br /&gt;
* [[Chlorpromazine]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Antipsychotics]]&lt;br /&gt;
[[Category:Phenothiazines]]&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>